Investor · Operator · Southern California

JC Ruffalo

Partner, Cove Fund

I've spent 25 years inside Southern California's startup ecosystem as a founder, an accelerator director, and a seed investor. That combination of operating experience and network is how I find companies early and how I add value after the investment: strategic introductions to customers, co-investors, and follow-on capital, and hands-on help at every stage, from the first round through growth and exit.

Operator
Three-time founder who has started, scaled, and sold businesses, and knows what it takes to build a company and raise the capital to do it
Builder
I love to build. First my own startups, then the Octane OC LaunchPad accelerator, and now the Cove Fund III portfolio and the firm's next fund
Investor
Partner at Cove Fund since 2021. Twenty seed investments across enterprise software, healthcare technology, and frontier systems, with $14.4M deployed and active follow-on reserves
20
Seed investments
Cove Fund III
$14.4M
Deployed across the
Cove Fund III portfolio
$4.6B
Exit value generated by
LaunchPad alumni
$2.5B
Raised by alumni of the
LaunchPad accelerator
About

Who I am

I'm JC Ruffalo, a Partner at Cove Fund since 2021. I've helped back early-stage founders across Southern California since 2014.

I came to investing as a founder. I started three companies before I turned 30: an action-sports apparel brand, a digital marketing agency, and a heavy-equipment trading business. That is the operating lens I bring to the work. I've sat on the founder's side of the table, and I remember what it takes.

Before Cove, I was Managing Director of the LaunchPad accelerator at Octane OC from 2014 to 2021, working hands-on with founders. Those companies have since raised more than $2.5B and produced multiple IPOs and acquisitions. My path went from entrepreneur to accelerator director to investor, and that operator's perspective shapes how I work today.

I like getting in early with technical founders building real products in enterprise software, healthcare technology, and frontier systems, then staying close as they grow.

What connects all of it is a simple belief: the best companies are built on relationships and trust earned over time. I back founders who understand their customer better than anyone else in the room, who build cultures people want to be part of, and who keep going when the round is hard and the market is quiet. My job is to see them early, before the consensus forms, and to be the first call when something breaks.

I went to Chapman University and never left Southern California. I'm married with two daughters, and this is home. Outside the fund, I put my time into the ecosystem itself: judging pitch competitions, mentoring first-time founders, and mapping the region's capital so the next generation of builders can find it faster. Southern California produces more technical founders than it has capital to back them, and closing that gap is work I plan to keep doing for a long time.

JC Ruffalo
JC Ruffalo
Partner, Cove Fund
Irvine, California

A few highlights

  • Sourced Cove Fund III investments including Quantum Elements, Occuspace, iCardio, 3Laws, XILO, VECKTA, BLNG, Eira Bio, Melio, Visaic, Wethos, and Exokeryx
  • 3Laws Robotics: sourced at Caltech, backed at seed, acquired by Amazon in 2026 as the first Fund III exit
  • iCardio: AI cardiac imaging, invested alongside round lead Cedars-Sinai Technology Ventures
  • Managing Director, Octane OC LaunchPad accelerator, 2014 to 2021
  • LaunchPad alumni include DTx Pharma ($1.1B acquisition by Novartis), RxSight (IPO), Acorns, and Hyperice
  • Chapman University alumnus, lifelong Southern Californian
Laguna Beach shoreline
Selected Outcomes

Results, realized and in motion

Cove Fund III · Deployed
$14.4M

Across 20 seed investments and 14 follow-ons, with reserves active for the strongest performers.

Acquisition · First Fund III Exit
3Laws → Amazon

CalTech robotics-safety software, acquired Q2 2026 at ~1.8x and ~41% IRR.

LaunchPad Alumni · Acquisition
$1.1B · DTx Pharma

RNA therapeutics company acquired by Novartis.

LaunchPad Alumni · IPO
RxSight

Medtech IPO from the LaunchPad community (Nasdaq: RXST), alongside Acorns and Hyperice.

Exit · 2026
3Laws Robotics
Acquired by Amazon
Caltech spinout · Sourced by JC · Backed at seed by Cove Fund III
The pattern behind the outcomes

Early, technical, and close

3Laws Robotics came out of Caltech. I sourced the company, Cove backed it at seed, and Amazon acquired it in 2026. Quantum Elements, Occuspace, and iCardio followed the same playbook: find technical founders early, back them at seed, and stay close through follow-ons and the exit.

Cove Fund III — Active Portfolio

Cove Fund III

20 Companies
$14.4M
Deployed (~60% of $24M)
18
Active Companies (20 total)
1.09x
Gross MOIC (all-in)
~1.8x
First Realized Exit (3Laws · Amazon)
Seed stage · Southern California · Partner · data as of June 30, 2026, updated for subsequent events through August 31, 2026. A 2022-vintage fund in year four: positions are carried at FMV or cost and are early in the J-curve, with follow-on reserves active. 0.06x DPI in year four, above the 0.01x Cambridge Associates upper-quartile benchmark for 2022-vintage US venture funds. Click any column header to sort.
See the full Cove Fund III portfolio
CompanySectorFirst Inv.StatusNotes / Outcome
Content.One (Zesty.io)Content management & web platform SaaS / MarTech11/2021 Active Note + equity · going well · steady growth
iCardioAI-powered cardiac imaging HealthTech / AI3/2026 Active · New $4.5M seed led by Cedars-Sinai Technology Ventures · March 2026 · held at cost
3Laws RoboticsCalTech robotics safety software Deep Tech / AI9/2024 Amazon Acquisition Acquired by Amazon · closed Q2 2026
XiloInsurance quoting & sales automation InsurTech / SaaS8/2022 Portfolio Leader Going well · strong growth · new AI product launched · positioning for Series B
Carro / VYRLCollaborative commerce / dropship eCommerce / B2B9/2025 Breakout Going well · exceptional growth over the last 18 months · Cove-led follow-on June 2026
BLNGJewelry intelligence platform · B2B SaaS eCommerce / AI2/2025 Breakout Quarter Going well · enterprise wins in luxury retail · Seed II co-led by Cove
Quantum ElementsQuantum digital twin software Deep Tech / Quantum3/2026 Technical + Commercial Breakout Going well · quantum digital twin work with AWS · peer-reviewed publication · oversubscribed seed extension
SigmaSightLitigation intelligence · B2B SaaS LegalTech / AI12/2024 Strong Traction Going well · growth · Series A prep
OccuspaceSpace utilization analytics PropTech / AI8/2023 Portfolio Leader Going well · strong growth · federal contract vehicle secured · deployments expanding · follow-on July 2026
VisaicImmersive fan experience platform Media / Sports Tech5/2024 Strong Growth Going well · strong growth · new customers and early renewals
VECKTAEnergy transition marketplace ClimateTech / Marketplace6/2022 Series A Signed Series A signed, pending close · Cove follow-on August 2026
Eira BioOncology & women's health therapeutics BioTech / Oncology11/2025 Solid Execution Lead program on track · second program advancing · on budget
MelioCulture-free blood pathogen detection MedTech / Diagnostics5/2024 Active CARB-X grant awarded · culture-free pathogen detection
Time MachineAI onboarding & training for sales teams AI / B2B SaaS9/2025 Active Going well · growth · Series A prep
CelitechWhite-label eSIM for travel operators TelecomTech / B2B2C6/2022 Active Cove-led seed · Series A prep
CenfireFabless semiconductor · MEMS relay tech Semiconductors / Deep Tech1/2026 Seed-2 Silicon MEMS relay tech · Seed-2 closed · initial market T&M/ATE
Wethos AIDecision intelligence for teams AI / Decision Intelligence7/2024 Series A in market Raising Series A · strong customer traction
ExokeryxExtracellular vesicle extraction BioTech / Diagnostics9/2024 Monitoring First product revenue · commercial ramp is the near-term focus
CARI HealthReal-time medication monitoring HealthTech7/2022 Active Real-time medication monitoring · growing clinical footprint
Prior Role · Octane OC · 2014–2021

LaunchPad Hall of Fame

Top 10 Alumni
Founders working through a plan at a whiteboard
2014–2021

Seven years at the whiteboard with founders

LaunchPad was hands-on work: office hours, pitch prep, investor introductions, and the hard conversations before a raise. I screened more than 10,000 companies and advised more than 500 through the program. The alumni have since raised more than $2.5B and produced multiple IPOs and acquisitions.

Companies JC supported through the Octane OC LaunchPad accelerator (2014–2021). LaunchPad was an accelerator program, not an investment vehicle — figures below reflect company valuation growth and outcomes during and after program participation, evidencing deal-sourcing and ecosystem quality, not fund returns or realized gains. Click any column header to sort.
10
Hall of Fame Alumni
5
Exits / IPOs
$2.5B
Capital Raised by Alumni
$4.6B
Capital via Exits
See the full LaunchPad Hall of Fame table
CompanyVal. at LaunchPadLatest Post-MoneyVal. GrowthOutcomeNotes
DTx PharmaRNA therapeutics · San Diego $6M$1.10B (Novartis acq.) 183xAcquired · NovartisAcquired by Novartis in 2023; RNA therapeutics for neuromuscular disease
HypericeRecovery tech · Irvine, CA $8M$850M (Series B) 106xActive · Series BRecovery technology; Series B at an $850M valuation
AcornsConsumer fintech · Irvine $19.5M (Series B, Mar 2014)$1.8B (Series F, 2022) 92xActive · Series FConsumer fintech; latest round at $870M post-money
NovaSignal (Neural Analytics)Brain health diagnostics · Los Angeles $7.7M$93M (last priced round) 12.1xAcquired · NeuraSignal, 2023Robotic brain-health diagnostics; acquired by NeuraSignal in 2023
BontiBotulinum toxin biotech $22.3M$195M 8.8xAcquired · AllerganBotulinum toxin biotech; acquired by Allergan
RxSightAdjustable intraocular lenses · Aliso Viejo, CA $266M$2.2B (2024 offering) 8.3xIPO · Nasdaq: RXSTLight-adjustable intraocular lens; Nasdaq IPO in 2021
SentryCardPayment security fintech $12M$60M (Series D, 2021) 5.0xActiveBiometric payment card; active
NGD SystemsStorage semiconductor · Irvine $22.6M$104M (2019) 4.6xActiveComputational storage semiconductors; active
LensGenOphthalmology devices · Irvine $19.2M$76.2M 4.0xActiveAccommodating intraocular lens in development; active
MavenlinkPSA software $61.4M$235M 3.8xMerged · KantataProfessional services software; merged with Kimble to form Kantata in 2022
Methodology: Octane OC LaunchPad was an accelerator program that supported these companies during JC's tenure (2014–2021); it did not invest capital, so figures reflect company valuation growth and outcomes, not fund returns or realized gains. "Val. at LaunchPad" is the post-money of the company's first priced round during JC's tenure (2014 to 2021); rounds before 2014 are not used; "Latest Post-Money" is the most recent priced financing, IPO, public offering, or acquisition value per PitchBook (accessed Sept 17, 2026). Acorns: Series B Mar 2014 ($19.5M post) to Series F Mar 2022 ($1.8B). RxSight LaunchPad-era mark is the $266M post-money Series H (Apr 2017, Visionary Venture Fund among investors); $2.2B is implied by the May 2024 public offering at $56 per share. Neural Analytics operated as NovaSignal and was acquired by NeuraSignal in 2023 for an undisclosed amount; $93M is its last priced round. SentryCard $60M from the July 2021 Series D; a 2025 round was undisclosed. NGD Systems $104M from Oct 2019. DTx valuation based on a conservative $6M LP-era mark; actual entry likely lower. Public company figures reflect the last offering price, not current market capitalization.
Community & Reach

The Southern California startup ecosystem

I've spent 25 years in SoCal's innovation economy and built an extensive network of founders, investors, operators, and institutions. This is our ecosystem, mapped so founders can use it.

Founder Resource

The Southern California Capital Map

A public, filterable directory of every fund, angel network, accelerator, and program writing checks between Santa Barbara and San Diego. Use it whether you are raising your first round or looking for the right program.

83Funds & angel networks
32SoCal accelerators & programs
18National programs
14Community organizations
18University programs
9Founder tools & resources
Open the map →

Relationship capital

At Cove Fund, that network extends to our investors. Our LPs are entrepreneurs, physicians, C-suite executives, fund managers, and service providers across a wide range of industries, and they are actively engaged in seeing deals alongside us and advising the companies we back. We call this relationship capital, and it is our strategic value to the entrepreneur.

Cove Investor Community
94 active members

A collaborative community of LPs across industries. They get deeply engaged, looking at deals with us and advising the companies together.

Investor Network
1,500+ investors

VCs, family offices, and strategics built over seven years running Octane's flagship accelerator and five years at Cove.

Monthly Screenings
How LPs add value

Members join monthly screenings, ask the hard questions, dig into the companies, and sit on diligence panels. After the check, they open doors to customers, key hires, co-investors, and strategic partners.

Palm-lined street by the ocean in Newport Beach
Approach

Investment Philosophy

Deal flow through ecosystem depth

Deal flow is driven by a network spanning key innovation hubs, built through years operating at the center of founder, university, and investor ecosystems. Rooted in Southern California but national in reach, surfacing high-potential companies before they become broadly visible. Cove Fund III reviewed 4,762 companies over the life of the fund, six times the volume of Fund II, and funded 20 of them, about 0.4% of the pipeline.

We build the relationships early.

Conviction over diversification

At the seed stage, outcomes are driven by a small number of breakout companies. The strategy identifies these early, supported by a decade of pattern recognition and data-backed selection, then concentrates time, conviction, and follow-on capital behind the strongest positions.

We back people first.

Operators on the board

We partner closely with founders through the most critical stages of company formation and early growth — strategic positioning and narrative, customer and investor introductions, and navigating the Seed → Series A transition.

We help companies cross the hardest gap: early traction to institutional scale.
20
Cove Fund III Portfolio Cos.
$14.4M
Deployed · Cove Fund III
$2.5B
Raised by LaunchPad Alumni
$4.6B
LaunchPad Exit Value
10,000+
Companies Evaluated
Figures reflect JC Ruffalo's active management on Cove Fund III and his role at the Octane OC LaunchPad program (2014–2021).
Basis of presentation. Fair market values (FMV) are estimates based on run-rate revenue multiples and NTM multiples, and are subject to change. Past performance is not indicative of future results. Certain metrics include unrealized positions and do not represent actual distributions. Track record figures are presented on a gross basis before management fees, carried interest, and fund expenses.
Contact

Let's talk

Building something early in enterprise software, healthcare technology, or frontier systems? I'd love to hear from you.

Email me LinkedIn